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Abstract
Despite rapid advances in genomic technology, our ability to account for phenotypic variation using genetic information
remains limited for many traits. This has unfortunately resulted in limited application of genetic data towards preventive
and personalized medicine, one of the primary impetuses of genome-wide association studies. Recently, a large proportion
of the ‘‘missing heritability’’ for human height was statistically explained by modeling thousands of single nucleotide
polymorphisms concurrently. However, it is currently unclear how gains in explained genetic variance will translate to the
prediction of yet-to-be observed phenotypes. Using data from the Framingham Heart Study, we explore the genomic
prediction of human height in training and validation samples while varying the statistical approach used, the number of
SNPs included in the model, the validation scheme, and the number of subjects used to train the model. In our training
datasets, we are able to explain a large proportion of the variation in height (h
2 up to 0.83, R
2 up to 0.96). However, the
proportion of variance accounted for in validation samples is much smaller (ranging from 0.15 to 0.36 depending on the
degree of familial information used in the training dataset). While such R
2 values vastly exceed what has been previously
reported using a reduced number of pre-selected markers (,0.10), given the heritability of the trait (,0.80), substantial
room for improvement remains.
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Introduction
Few examples exist of findings from Genome Wide Association
Studies (GWAS) being applied to preventive and personalized
medicine. Despite the success of GWAS in the discovery of many
novel disease variants, the variants identified as being statistically
significant typically account for minimal fractions of the genetic
variance, even for highly heritable traits [1]. This so-called
‘‘missing heritability’’ has prompted a wide array of explanations,
ranging from poor modeling (e.g., unaccounted epistatic effects)
[2,3], insufficient sample sizes [4], sparse genetic coverage [5], rare
variants [6], undetected CNV effects [7], and over-estimated
heritability [1,8,9]. While all of these problems (and possibly others
[10]) likely contribute to some extent [11], recent articles by Yang
et al. [12] (hereafter, the Yang Study), and others [13,14] suggest
that the primary culprit may be a mismatch between the actual
genetic architecture and the statistical techniques applied.
Typically, predictive models from GWAS are constructed using
a small number of Single Nucleotide Polymorphisms (SNPs) that
have been pre-selected using extremely low p-values derived from
single-marker regressions. This approach is most sensible under
the assumption that only a few loci affect the trait of interest;
however, it performs poorly for complex traits [14,15], which
could be subtly affected by many loci [16]. Drawing on methods
commonly used in animal breeding [17], the Yang Study built a
model for human height (a model trait that has recently received
much attention because of its high heritability and relatively
reliable phenotyping) with hundreds of thousands of SNPs jointly
considered (see Visscher et al. [18] for an expanded commentary
on the methodology employed).
Using a Whole Genome Prediction (WGP) method, the authors
from the Yang Study estimated that common SNP variation
(through Linkage Disequilibrium (LD) with causal polymorphisms)
explained 45% of the phenotypic variance, thus accounting for
more than 50% of the expected heritability of height, which is
reported to be approximately 80% [19,20]. These results suggest
that the underlying genetic architecture of human height likely
consists of numerous polymorphisms of small effect, resembling
the infinitesimal model of quantitative genetics [21,22]. Recent
studies suggest similar conclusions for other complex traits,
including schizophrenia and bipolar disorder [23], blood lipid
levels [24], and body mass index [25], suggesting a broader utility
for the approach of WGP methods to account for genetic variance
of important complex human traits.
The results of the Yang Study are particularly exciting due to
their implications for eventual application to preventive and
personalized medicine. However, a remaining question is the
extent to which WGP methods improve the prediction of yet-to-be
observed phenotypes, given the distinction between proportion of
variance accounted for (as a measure of goodness of fit) and
predictive accuracy (Figure 1). Heritability estimates can be
regarded as measures of goodness of fit (see Materials and
PLoS Genetics | www.plosgenetics.org 1 April 2011 | Volume 7 | Issue 4 | e1002051Methods for a discussion), yet it is well known that increasing
goodness of fit will not necessarily lead to increased predictive
accuracy in future samples, due to issues such as over-fitting [26].
In this study, we examine the relationship between estimates of
variance accounted for and predictive ability using WGP methods.
Using three different statistical approaches and validation designs,
we examine how these relationships change as a function of the
density of SNPs included, the size of the training sample, and the
degree of familial information included in the training sample.
Results
Using data from the Framingham Heart Study [27,28], we built
models for the age and sex adjusted height of 5,117 adults using
between 2,500 and 400,000 SNPs. Participants included in our
analyses were individuals greater than 18 years old from the
original (N=1,493) or the offspring (3,624) cohorts; 2,311
individuals were male and 2,806 were female. Height ranged
from 141.6 cm to 198.1 cm with a mean of 167.4 cm
(SD=9.5 cm). Markers were incorporated into statistical models
in two ways: (i) regression of adjusted height on marker genotypes
via the Bayesian LASSO (BL) [29] ; (ii) Bayesian random effects
models using a marker-based (realized) relationship matrix
between individuals (G). There are multiple ways to map marker
genotypes into G and none is considered generally superior. Here
we considered those used by Hayes and Goddard [30] and the
Yang Study; the two models are denoted as G
H and G
Y,
respectively, producing altogether three separate models. Good-
ness of fit was evaluated by means of the estimated residual
variance and the proportion of variability accounted for by the
fitted model in the training (TRN) dataset, R2
TRN. In addition,
models were compared based on the estimated heritability,
^ h h2~
s2
g
s2
p
(where s2
g is the variance attributed to additive genetic
effects and s2
p is the total phenotypic variance) and the Deviance
Information Criterion (DIC) [31].
Table 1 gives the estimated R2
TRN, ^ h h2, and DIC by model and
number of SNPs. Both R2
TRN and ^ h h2 increase as more SNPs are
included in the model, indicating an improved model fit. With
400,000 SNPs, the R2
TRN statistic indicates that predicted genetic
values (see Materials and Methods for a detailed description of
terminology) accounted for 95% of the variability in adjusted
height (R2
TRN), and the estimated heritability (^ h h2,0.83) is close to
what has been previously reported for this trait. Based on the trend
observed, any further increases in common SNPs would likely
produce a minimal increase in the proportion of accounted
variability.
As the number of markers increases, DIC decreases, indicating
that information is continually being added to the model. This
conforms with expectations under an infinitesimal model where
the proportion of variance at Quantitative Trait Loci (QTLs)
accounted for by regression on SNPs should increase with marker
density [32]. Moreover, for any given number of SNPs, differences
in the estimated residual variance, R2
TRN, and heritability estimates
across statistical approaches were small. We do not report ^ h h2 based
upon the Bayesian LASSO: while formulae have been proposed to
arrive at estimates of genetic variance from estimated marker
effects and allele frequencies, they are problematic as they rely on
the unrealistic assumption of linkage equilibrium between markers
[33]. However, the similarity in R2
TRN across models suggests that
the proportion of variance accounted for by the Bayesian LASSO
is similar to that of the two other methods.
To evaluate predictive ability, we used three different validation
designs. Approach A- 10-fold cross-validation (CV) with assignment
of individuals to folds at random. Because of the multiple
generations present in the Framingham dataset, it is possible for
children to be used to predict their parents in this design, which
does not correspond to a standard prediction problem. To avoid
this situation, we employed Approach B- using parents to predict
children, we constructed a training dataset (TRN) with 1,493
parents and a testing dataset (TST) comprising offspring
(N=3,624). Because of the structure of the data, the size of the
training sample used in Approach B is much smaller than that
used in Approach A. Theory and empirical evidence [32] suggest
that the accuracy of estimates of genetic values depends on the size
of the training sample. To explore how much the size of the
training sample affects predictive ability, we devised Approach C-
randomly split the sample 10 times into TRN (N=1,493) and
TST sets (N=3,624). Therefore, Approaches B and C differ in the
way individuals were assigned to TRN and TST sets but not on
the size of the TRN set. While approaches A and C allow for
replicate datasets (10 in this study), Approach B is constrained to
one replicate. As an aside, replicate datasets yielded highly similar
R2 values, with an average coefficient of variation of ,0.5%.
Table 2 displays the estimated R2 evaluated in validation (TST)
samples (R2
TST) by model, validation design, and number of SNPs.
Within all validation designs, differences between models were
very small. To better visualize the relationship between R2, ^ h h2,
and the number of SNPs, we average the results across modeling
techniques (Figure 2). Predictive accuracy increased with the
number of SNPs, reaching an R2
TST of 25% in the 10-fold CV
design when 400,000 SNPs were used. In the other two validation
designs (approaches B and C), R2
TST is considerably smaller than
in the 10-fold CV, reaching a maximum R2
TST of 13% (15%) in
the 2-generation and random training-testing designs, respectively.
The 10-fold CV uses larger relative training datasets than
approaches B and C, which can affect prediction accuracy in at
least two ways. First, using larger training datasets is expected to
increase accuracy, even with nominally un-related individuals
[32]. Concurrently, when the size of the training dataset is
increased, the likelihood of having multiple close relatives included
in the training data also increases, and, as we discuss below, for a
Author Summary
While previous genome-wide association studies have
implicated numerous loci associated with complex traits,
such loci typically account for a very small proportion of
phenotypic variation. However, a recent study using
height as a model trait has illustrated that common single
nucleotide polymorphisms can explain a large amount of
genetic variance when evaluated through whole-genome
statistical models. However, it is unclear to what extent
higher proportions of explained variance will translate into
improved predictive accuracy in future populations. Here
we evaluate the predictive ability of whole-genome
models for human height while varying the modeling
approach, the size of the training population, the
validation design, and the number of SNPs. Our results
suggest that whole-genome prediction models can yield
higher accuracy than what is commonly attained by
models based on a few selected SNPs; yet, given the
heritability of the trait in question, there exists room for
improving prediction accuracy. While gains in predictive
accuracy are likely to be small based on more expansive
genotyping, our results indicate that more substantial
benefits are likely to be gained through larger training
populations, as well through the inclusion of related
individuals.
Predicting Complex Traits
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of close relatives used to train the model. Unfortunately, the CV
designs we evaluate do not allow exact separation of the relative
effect of sample size from that of other contributing factors.
The predictive accuracy of WGP methods is known to depend
on how closely related individuals in the training and validation
samples are to each other [34–36]. The Framingham Heart Study
dataset contains varying degrees of familial relationships (e.g.,
parents, offspring, and siblings) and provides the opportunity to
study how prediction accuracy is affected by including familial
members in the training population. To demonstrate this effect,
for every individual in the 10-fold CV testing datasets, we
calculated the number of close relatives (parents, full sibs, half sibs
and offspring) present in the training dataset used to derive its
prediction. This was calculated as follows: let sij be an index which
takes the values of 1 if individuals i,j ðÞ are either full sibs or a
parent-offspring pair, 0.5 if i,j ðÞ is a half-sib pair, or 0 otherwise.
Using this system, a score was calculated as si~
PN
j~1 sijd i,j ðÞ
where d i,j ðÞ equals one if individual i is in the testing population
and individuals j is in the training population, and zero otherwise.
Using this score we classified individuals into four groups (si~0,
0vsiƒ1, 1vsiƒ2, siw2) and calculated the average R2
TST
within each group after pooling the groups across CV folds.
Figure 3 depicts the relationship between the number of close
relatives in the training population, the number of SNPs, and
R2
TST averaged across the three modeling techniques (see Table S1
for exact performance values). As expected, when the number of
close relatives in the training dataset increases, the predictive
ability increases. The relative increase in predictive ability with
increasing SNP density is dependent upon the number of close
relatives included in the model, with more drastic increases in
predictive ability observed when more than two close relatives are
included within the training dataset. When 400,000 SNPs are
included, the average R2
TST is 0.154, 0.267, 0.322, and 0.363 when
si~0, 0vsiƒ1, 1vsiƒ2, and siw2, respectively.
Discussion
Our results are concordant with the Yang Study, demonstrating
that much of the variance in human height can be accounted for
using WGPmethodsbased oncommonSNPs.However,therearea
number of differences between our studies that warrant consider-
ation. First, we focused on prediction accuracy and several factors
that may affect it, while the Yang Study focused on estimating the
proportion of variance in human height that can be explained by
commonSNPs. While we reportheritability estimates, we stressthat
our estimates of ^ h h2 are not comparable to the ^ h h2~0:45 reported by
the Yang study because, unlike the Yang Study, we did not restrict
our sample to be composed of nominally unrelated individuals.
While removing related individuals may allow estimation of genetic
variance solely attributable to common SNPs through LD with
causative polymorphisms, the use of exclusively un-related individ-
uals may harma model’s ability to separate genetic signal from non-
genetic components [36] and therefore measures of prediction
Figure 1. A simplified representation of assessment of goodness of fit in a training dataset and of predictive ability across a
population: an example with the Framingham population.
doi:10.1371/journal.pgen.1002051.g001
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predictive powerofcommonSNPs.Inaddition,we focusedonadult
height ($18 years old), while the Yang Study included individuals
$16 years of age, which may induce added non-genetic variability
as some teenagers will still be growing at that age. Finally, there
likely are differences between the Framingham population and the
Australian population used in the Yang study.
In all validation designs, we found that predictive ability
increased with the number of SNPs, suggesting that a large
number of SNPs are needed to capture genetic variance at QTLs.
These results are similar to findings in the animal breeding
literature for infinitesimal traits [37,38]. Our results also suggest a
diminishing rate of return, with the difference in predictive ability
between 80,000 and 400,000 SNPs being only ,6% in the 10-fold
CV. However, the number of markers at which this ‘‘plateau’’
occurs is likely to depend on multiple conditions such as the extent
of LD in the population and the number of individuals in the
training data. Indeed, other studies using populations with smaller
effective population sizes (Ne), and therefore larger LD spans, have
reported high accuracy with much sparser coverage [37,38].
A recent study [39] reported a decrease in predictive ability of
human height for models with p-value inclusion thresholds greater
than 5610
23; suggesting that prediction accuracy may be harmed
by including a large number of markers in a predictive model.
However,animportant difference betweenthisstudyand oursisthat
in the former, marker effects were estimated using a fixed effects
model while we use a Bayesian mixed model framework where all
unknowns are modeled as random effects. Unlike the fixed effects
approach,the Bayesian mixed modelframeworkinducesa shrinkage
of estimates which, to some extent, controls over-fitting and seems to
prevent a reduction in predictive ability in models with p&n.
Importantly, we found no drastic differences between any of the
statistical methods we considered. This is not surprising given that all
three methods are based on an underlying additive model and that
height likely conforms to an infinitesimal architecture. Moreover,
these results are in agreement with findings reported in the animal
breeding literature [40] which report small differences in predictive
ability between contrasting methods. However, this conclusion may
not apply to traits with simpler architecture, e.g., traits where major
associated variants explain a substantial proportion of genetic
variance. In these cases, models using marker-specific shrinkage of
estimates such as the BL may outperform models such as G
H or G
Y
where all markers are equally weighted.
Theoretical [32,41] and empirical studies [37,38] demonstrate that
prediction accuracy increases monotonically with the size of the
training population. Our results showed the same pattern, with a
,70% increase in predictive ability when the size of the training
dataset was increased from 1,493 to 4,506. A practical question
resulting from this is how many individuals are needed to attain a
certain predictive accuracy. The answer to such question depends on
several factors such as trait heritability, marker density, Ne, the genetic
architecture of the trait, and the degree of propinquity between
individuals whose phenotypic outcomes are to be predicted and those
used to train the model. For nominally unrelated individuals under an
infinitesimal model for a trait with h
2=0.8, Goddard and Hayes [41]
report that for effective population sizes of 100 or 1,000, achieving a
correlation between predicted and true genetic values of 0.7, or
equivalently, an R2 between predicted and realized height of about
0.39 (calculated as 0. 7
260.8 ), requires training samples of
approximately 4,000 and 50,000 individuals, respectively. However,
as our results illustrate, prediction accuracy can be increased
substantially by using information from related individuals.
Simulation [34] and empirical studies [35,36] in animal
breeding have suggested that the prediction accuracy of WGP
methods depends on familial relationships between individuals in
the training and validation samples. This was confirmed by our
analysis: in the 10-fold CV with 400K SNPs, the R2
TST of
individuals whose prediction was derived without using informa-
tion from close relatives in the training dataset (R2
TST~ 0.15) is
much smaller than that obtained when direct relatives were
included in the training dataset (R2
TST~ 0.27, 0.32, and 0.36, for
individuals with0vsiƒ1, 1vsiƒ2, and siw2 respectively). This
occurs because WGP methods exploit genetic similarity across
individuals and because recent family history plays a central role in
determining genetic similarity. In light of this observation, one
may wonder: does the use of genetic markers simply recapitulate
pedigree-relationships? Several studies in animal and plant
breeding have demonstrated the superiority of WGP over pedigree
methods [40,42–44] suggesting that markers convey more
information than that provided by pedigrees. In particular,
molecular markers can account for similarity/differences due to
common ancestry not traced by the pedigree, and, more
Table 1. R-squared statistic measured in the data used to train the model (R2
TRN), estimated posterior mean of heritability (^ h h2), and
Deviance Information Criterion (DIC) by model and number of SNPs (where K=1,000).
Number
of SNPs Bayesian Lasso
1
Genomic
Relationship G
Y
Genomic
Relationship G
H
R2
TRN DIC R2
TRN ^ h h2 DIC R2
TRN ^ h h2 DIC
2.5K 0.33 32,920 0.36 0.21 32,883 0.34 0.26 32,912
5.0K 0.47 32,666 0.49 0.31 32,605 0.48 0.37 32,642
10K 0.65 32,106 0.69 0.47 31,950 0.66 0.52 32,081
20K 0.79 31,359 0.82 0.60 31,124 0.79 0.65 31,365
40K 0.87 30,564 0.89 0.70 30,201 0.87 0.74 30,564
80K 0.92 29,629 0.93 0.77 29,220 0.92 0.80 29,685
160K - - 0.95 0.79 28,925 0.93 0.81 29,416
400K - - 0.96 0.81 28,444 0.94 0.83 29,017
Estimates were obtained by fitting models to height adjusted by sex and age and using all available data (N=5,117).
1For the Bayesian LASSO, due to high memory requirements, only models including up to 80K markers were considered. This model does not include a genetic variance
parameter, therefore it does not yield a direct estimate of heritability. For this reason heritability is not reported for this model.
doi:10.1371/journal.pgen.1002051.t001
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lian segregation. Relative to plant or animal breeding populations,
the level of inbreeding in humans is smaller, with the quality of
pedigree information typically being poorer, if it is even available.
Therefore, the benefits of using markers relative to pedigree
information for prediction could be even larger in humans.
Clearly, there exists a redundancy between the information
conveyed by the pedigree and that provided by markers. However,
this redundancy is not complete and there may be benefits to
incorporating pedigree and marker information in the model. For
example, Vazquez et al. (2010) used data from US Holsteins to
quantify the prediction accuracy using pedigree-based predictions,
marker based WGP, and predictions combining pedigree and
markers. The study confirmed the superiority of marker-based
models (with a correlation of 0.42 for pedigree-based predictions
and 0.649 for the marker-based predictions in CV) and found that,
when more than 10,000 markers were available (for a Holstein
sample), combining pedigree and molecular marker data was no
better than using marker data only. This suggests that dense
markers are able to capture genetic similarity due to recent family
history as well as other sources of genetic similarity not described
by pedigrees. Therefore, we speculate that the largely incomplete
pedigrees of most humans will provide little to no additional
information for the prediction of complex traits, especially given
the high density of markers typically available.
A pertinent question is whether a WGP model fitted to one
population can be used to predict phenotypes in a distantly related
population; this remains, so far, an un-answered question [14]. The
prediction accuracy of WGP methods depends on the patterns of
LD between markers and QTLs; these are likely to change across
populations and therefore it is reasonable to expect relatively poor
prediction accuracy across populations. This does not represent a
failure of the methodology per se, but instead a feature that needs to
be considered when applying these methods for prediction.
Populationstructure, admixture, or other populationfeatures can
lead to spurious associations and affect prediction accuracy;
therefore accounting for these features has been an important focus
for GWAS analyses [45]. A pertinent question is the extent to which
structure and other forms of genetic diversity are accounted for by
WGP methods. An important difference between WGP methods
and standard single-marker regressions is that, when all markers are
jointly modeled, population structure, admixture, familial relation-
ships, genetic differences between full-sibs within a family, and
genetic relationships between nominally un-related individuals are
allimplicitlyaccountedfortothe extentthatwhole-genomemarkers
describe them. Indeed, regressing a phenotype simultaneously on a
set of whole-genome markers is equivalent to regressing the
phenotype on all marker-derived principal components, with a
degree of shrinkage in the estimated effect for each component that
is proportional to its associated squared-singular value [46]. The
Framingham population consists of individuals from various
European ethnic backgrounds and height is typically correlated
with northern European ancestry; therefore, population stratifica-
tion is likely contributing to prediction accuracy [47]. Conversely,
the patterns of LD between markers and QTL may be different
across sub-populations and this may hinder predictive ability,
especially when the sub-populations were separated for many
generations [48]. The exact nature of this tradeoff is difficult to
establish and constitutes an important area of future exploration.
In conclusion, WGP methods provide a promising approach for
the prediction of complex traits. The results of the Yang Study and
those reported in this study both support this conclusion: they
account for a larger proportion of the expected genetic variance
and, as our study indicates, are able to predict yet-to-be observed
phenotypes with greater success. Yet, it is apparent that predictive
ability depends to a large part upon how many close relatives are
included while training the model, and there is an apparent need for
improving the accuracy of predictions of nominally unrelated
individuals. Therefore, while whole-genome prediction of complex
human traits can yield more accurate predictions than those based
on models using a reduced number of markers, prediction of such
traits remains difficult and significant room for improvement exists.
Materials and Methods
Genotyping and Quality Control
Subjects weregenotyped using the Affymetrix GeneChip Human
Mapping 500K Array Set. For details on genotyping, see http://
www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=
phs000007.v3.p2. SNPs with call rates less than 90% and with a
minor allele frequency (MAF) less than 3% were excluded. The
remaining missing genotypes were imputed by sampling from a
Table 2. R-squared between predicted and observed values (R2
TST) estimated using different number of SNPs (where K=1,000),
models, and validation designs.
Number of SNPs 10-Fold CV
1 2-Generations design
2 Training-Testing Random
3
BL G
Y G
H BL G
Y G
H BL G
Y G
H
2.5K .097 .102 .098 .054 .035 .035 .064 .035 .033
5.0K .126 .130 .129 .066 .058 .061 .080 .059 .057
10K .166 .174 .168 .087 .088 .093 .099 .094 .088
20K .200 .204 .199 .106 .111 .115 .119 .119 .114
40K .217 .221 .216 .117 .118 .123 .128 .131 .126
80K .236 .237 .236 .124 .126 .129 .138 .139 .137
160K - .240 .240 - .130 .132 - .142 .141
400K - .247 .249 - .133 .133 - .146 .145
BL=Bayesian LASSO, G
H=Goddard-Hayes, and G
Y=Yang study (see Materials and Methods for elucidation).
110-fold cross validation, where the training set comprised 4,605–4,606 individuals.
2Models were trained using the original cohort (N=1,493) and predictive ability was assessed in the Offspring cohort (N=3,624).
3Data was assigned at random to a training set (N=1,493) and predictive ability was evaluated in the remaining individuals (N=3,624). This was repeated 10 times; each
time individuals were randomly assigned into training/testing sets. Results are averaged across the ten replicates.
doi:10.1371/journal.pgen.1002051.t002
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assumption of Hardy-Weinberg Equilibrium.
Genome-Wide Models for Human Height
In all models, age and sex-adjusted height of individual i, yi, was
expressed as yi~mzgizei where: m is an effect common to all
individuals, gi is a genetic value (i.e., a component of phenotypes
that can be attributed to genetic factors), and ei is a model residual
which captures all factors affecting the response not captured by
gi. The conditional distribution of the data is:
p(yjm,g,s2
e)~ P
n
i~1
N(yijmzgi,s2
e) ð1Þ
where, y~ yi fg , m is an effect common to all individuals, g={gi}i s
a vector of genetic values, and Ny ijmzgi,s2
e
  
is a normal density
for the random variable, yi, centered at mzgi, with variance s2
e.
All models were implemented in a Bayesian framework with
inferences based on the posterior distribution of the unknowns
given the data. Models differed in the number of markers used and
the way they were incorporated into gi. In the first group of
models, genetic values were assumed to be multivariate normal:
p(gjG,s2
g)~N(gj0,G,s2
g) ð2Þ
where g~ gi fg , G~ Gij
  
is a relationship matrix between
individuals i,j computed from marker genotypes and s2
g is an
additive variance parameter. This approach has been used in
many applications for modeling infinitesimal additive effects using
molecular markers [12,30,49–51]. We focus on those used by
Hayes and Goddard [30] (G
H) and the Yang Study (G
Y)t o
generate G from the marker data. In method G
Y, relationships are
standardized so that the average diagonal value equals one. In
order to make the genetic variance parameters comparable, this
Figure 2. We averaged the estimates of R2
TRN (measured in the training data), ^ h h2, R2
TSTCV (measured in a 10 fold cross validation),
R2
TST2gen (measured in a 2 generation validation), and R2
TSTTT (measured in a replicated Training-Testing validation) over the three
modeling techniques (BL, G
H,G
Y) and showed their relationship to the number of SNPs included in the model.
doi:10.1371/journal.pgen.1002051.g002
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H by dividing the entries of G
by the average diagonal value.
To estimate the remaining model parameters, we utilized a
Bayesian approach by assigning prior distributions to
H~ m,s2
e,s2
g
no
. We assigned a flat uniform prior to m, with
conjugate scaled inverse chi-square priors used for s2
e and s2
g,
implying a joint posterior density proportional to:
p(m,g,s2
e,s2
gjy)! P
n
i~1
N(yijmzgi,s2
e)
  
N(gj0,As2
g)x{2(s2
ejdfe,Se)x{2(s2
gjdfg,Sg)
ð3Þ
Samples from the posterior distribution of the above model were
obtained using a Gibbs sampler implemented in the R-language
(http://www.R-project.org). We specified the hyper-parameters in
[3] as dfe~5,Se~60,dfg~5,Sg~60
  
. These values give a prior
expectation of the variance of genetic values and of model
residuals that are equal to approximately one half of the sample
variance of adjusted height. With 5 degrees of freedom, priors
have finite mean and variance, and a relatively small influence on
inference.
In a third model, genetic values were described as a linear
regression on marker covariates: gi~
P L
l~1
Xilbl. Here, bl is the
additive effect of the l
th marker. Marker effects were inferred using
the Bayesian LASSO (BL) of Park and Casella [29]. This model
has been used successfully to model complex traits in genetic
applications [37,43,52]. This leads to the joint posterior distribu-
tion density:
p(m,b,s2
e,t2,cjy)! P
n
i~1
N(yijmz
X L
l~1
Xilbl,s2
e)
()
P
L
l~1
N(blj0,s2
et2
l )Exp(t2
l jl
2)
  
|x{2(s2
ejdfe,Se)G(l
2jd,c)
ð4Þ
where N blj0,s2
et2
l
  
denotes a normal prior assigned to bl
centered at zero and with prior variance equal to s2
et2
j ,
Exp t2
l
   l
2   
is an exponential prior assigned to the t2
l ’s , and
G l
2   d,c
  
is a Gamma prior assigned to the regularization
parameter l
2. This model was fitted using the BLR package [53]
in R. The use of SNP-specific conditional prior variances,
Var bj
   t2
j ,s2
e
  
~t2
j s2
e, allows for SNP-specific shrinkage of the
estimates of effects. This contrasts with models G
H and G
Y in
which all markers are equally weighted. The joint posterior
distribution given by [4] is indexed by several hyper-parameters.
In our application, those hyper-parameters were:
dfe~5,Se~60,c~0:55,d~1|10{6   
. These values give a prior
expectation of the residual variance that is about one half of the
sample variance of adjusted age and a relatively flat prior density
over a wide range of the regularization parameter l. We applied
the above-mentioned models using subsets of evenly-spaced
SNPs, ranging from 2,500 to 400,000. Due to limitations in
Figure 3. Averaged (across the three different models) estimates of R2
TSTCV (measured in a 10 fold cross validation) while varying
the number of close relatives (si) in the training dataset with 2.5K to 400K SNPs.
doi:10.1371/journal.pgen.1002051.g003
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BL (method 3) was 80,000.
Heritability and R-Squared
Heritability, ^ h h2~
s2
g
s2
p
~
s2
g
s2
gzs2
e
, is defined as the ratio of the
variance due to additive genetic factors, s2
g, relative to the
phenotypic variance, s2
gzs2
e, in the base population (in a
pedigree-model, this is the population from where the founders
were sampled, which is assumed to be comprised of un-related
individuals). This is also the squared correlation between genetic
values and phenotypes, and the proportion of variance accounted
for by genetic factors, both in the base population [54].
Heritability estimates (^ h h2) are commonly obtained by replacing
population parameters with estimates derived using Restricted
Maximum Likelihood or Bayesian procedures.
The R2 statistic is the ratio between the variance accounted for
by a model relative to the sample variance of the response. That is:
R2~1{
Var ^ e ei ðÞ
Var yi ðÞ
where Var ^ e ei ðÞis the sample variance of
predictive residuals derived from a model and Var yi ðÞ is the
sample variance of phenotypes. The R2 statistic is related to ^ h h2.
However, R2 measures the proportion of variance accounted for
by predicted genetic values in the sample, while ^ h h2 estimates the
proportion of phenotypic variance accounted by true genetic
values in the base population. Fundamentally, R2 ignores
inbreeding, relationships between individuals in the sample and
estimation errors; therefore, it is not a consistent estimate of
heritability [54,55].
The R2 statistic is sometimes evaluated in the same dataset that
was used to derive predictions, which tend to over-estimate
predictive ability. A better assessment of the ability of a model
to predict future data can be obtained using validation methods
[26]. We therefore distinguish two R-squared measures:
R2
TRN~1{
Var ^ e ei ðÞ
Var yi ðÞ
and R2
TST~1{
Var ~ e ei ðÞ
Var yi ðÞ
where: ^ e ei denotes a
prediction error derived when all available data, including the i
th
observation, was used to fit the model, and ~ e ei denotes a prediction
error derived when the validation set containing the i
th observation
was not used to fit the model, respectively. Therefore, R2
TRN
measures goodness of fit between the training data and the model
while R2
TST measures the ability of the model to predict future
observations.
Supporting Information
Table S1 R-squared between predicted and observed values
(R2
TST) estimated using different number of SNPs with different
numbers of relatives in the training populations averaged across
validation designs.
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